HomeQuestion

Is it safe to prescribe Invokana or Metformin for patients taking Biktarvy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Do you plan to initiate combination therapy with an SGLT-2 inhibitor and finerenone, instead of an SGLT-2 inhibitor alone, when treating patients with proteinuric chronic kidney disease and type 2 diabetes in light of the CONFIDENCE trial findings?

How has the use of CGMs informed or improved your management of patients with pre diabetes or diabetes not on insulin?

Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?

Would you consider transitioning patients older than 75 years of age with coronary disease from statins and/or other lipid-lowering agents to PCSK9 inhibitors given concerns for polypharmacy, provided their LDL levels remain at or below goal?

When do you think physicians should seriously consider prescribing PCSK9 inhibitors for the prevention of heart attack and stroke in people with ASCVD or diabetes, based on the results of the VESALIUS-CV trial?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

Is it safe to prescribe Invokana or Metformin for patients taking Biktarvy? | Mednet